Let Tandem do the thinking for you
NEW Tandem t:slim mobile app!*
Coming soon in May 2025
The t:slim X2™ insulin pump with Control-IQ™ technology can be used as a stand alone pump, or can be integrated with the Dexcom G7 or G6 continuous glucose monitoring (CGM)† system to activate the predictive insulin delivery technology.
The Control‑IQ advanced hybrid closed-loop technology makes it easier by using Dexcom CGM values to predict glucose levels 30 minutes ahead and automatically adjusts basal insulin every 5 minutes, to help increase time in range.1
NEW Tandem t:slim mobile app* coming soon in May 2025
Give yourself the freedom to more easily manage your diabetes with the Tandem t:slim mobile app*
Freedom to bolus
Bolus from your compatible smartphone* without touching your t:slim X2 insulin pump.
Freedom to be discreet
View pump data on your smartphone as a secondary display for your t:slim X2 insulin pump.
Freedom to be in the know
Automatically upload your pump data to the new Tandem Source platform.††
Why choose Tandem?
Working with you 24/7 to help you live more freely
- Simplify your routine with zero fingerpricks‡ and no multiple daily injections.
- Experience more than 90% time in range overnight.#,2
- Discreet, modern and simple to learn.
- Freedom to bolus from your smartphone* without touching your pump.
- 97% said it’s easy to use.3
Worry less about your diabetes
- Automatically predicts and helps prevent highs and lows.§
Now powered by Dexcom’s most accurare||,4 sensor
- Dexcom G7†
- To learn more about Dexcom G7, visit Dexcom.com.
Control-IQTM Technology
Predicting glucose levels 30 minutes ahead and suspending insulin, to help reduce the frequency and duration of lows.1,¶
Dexcom G7 CGM¶
Integration
Compatible with Dexcom G7 CGM requiring zero fingerpricks.‡
Updateable
Platform
Capable of remote feature updates, instead of waiting for a whole new pump!
Large, Colour Touchscreen
The t:slim X2 insulin pump was designed to be user-friendly, with an easy-to-read, easy-to-use interface.
Have you heard of our loan program?
At AMSL Diabetes, we strive to remove barriers to access to advanced glucose management technology. We're excited to introduce our tailored loan stream for t:slim X2 insulin pump, aimed at supporting early initiation and flexible management for type 1 diabetes patients.
Give it a Try
The Give it a Try initiative allows a two-month trial with the t:slim X2 insulin pump, subject to application approval and certain conditions. It provides an opportunity for individuals to experience the pump's benefits first hand.
Accelerate & Pump
Don't wait for your health insurance to mature, start pumping with a t:slim X2 insulin pump through AMSL Diabetes Accelerate & Pump program.
The Tandem t:slim Mobile App is an accessory intended for use as a connected software device that is able to reliably and securely communicate with compatible insulin pumps. Tandem Source is a web application intended to support glucose management through the display and analysis of information uploaded from Tandem insulin pumps. The t:slim X2 insulin pump is a portable insulin infusion pump, including sterile cartridge, that delivers insulin subcutaneously through a disposable infusion set. Dexcom CGM is a continuous glucose monitoring system indicated for the management of (type 1, type 2, gestational) diabetes in people age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated.
‡ If your glucose alerts and readings from Dexcom G7 do not match symptoms or expectations use a blood glucose meter to make diabetes treatment decisions. *Bolus delivery from the Tandem t:slim mobile app requires a compatible smartphone model and operating system, software version 7.8.1 onwards on the t:slim X2 insulin pump and additional training. †Dexcom G7 CGM sold separately. Subsidised Dexcom CGM is available through the CGM Subsidy Initiative via the NDSS for eligible individuals, for more information visit ndss.com.au/cgm. # Between the hours of 4 am to 7 am while using Control‑IQ technology. § As measured by Dexcom CGM. || Dexcom G7 and ONE+ are our Dexcom’s accurate CGM systems as compared to Dexcom G6. Control-IQ technology is not a substitute for active self-management of your diabetes. ¶ Control-IQ technology is only available with Dexcom G6 or G7 CGM. ^ Smart device sold separately. To view a list of compatible devices, visit amsldiabetes.com.au/mobile-compatibility. †† Uploads to the Tandem Source platform do not take place in real- time and should not be relied upon by healthcare providers, pump users, or caregivers for remote patient monitoring.
1. Forlenza GP, Li Z, Buckingham BA, Pinsker JE, et al. 2018;41(10):2155-2161. doi:10.2337/dc18-0771. 2. Breton MD, Kovatchev BP. One year real-world use of the Control-IQ advanced hybrid closed-loop technology. Diabetes Technol Ther. 2021;23(9):601-608. doi: 10.1089/dia.2021.0097. 3. Data on File. 4. Welsh JB, et al. Comparisons of Fifth-, Sixth-, and Seventh-Generation Continuous Glucose Monitoring Systems.
Australasian Medical & Scientific Ltd is a Dexcom company. ARTG-304681.